These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 75485)

  • 1. Non-appearance of injected fibroblast interferon in circulation.
    Edy VG; Billiau A; De Somer P
    Lancet; 1978 Feb; 1(8061):451-2. PubMed ID: 75485
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.
    Edy VG; Billiau A; De Somer P
    J Infect Dis; 1976 Jun; 133 Suppl():A18-21. PubMed ID: 932502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating interferon in rabbits after administration of human interferon by different routes.
    Cantell K; Pyhälä L
    J Gen Virol; 1973 Jul; 20(1):97-104. PubMed ID: 4356685
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.
    Billiau A; Heremans H; Ververken D; van Damme J; Carton H; de Somer P
    Arch Virol; 1981; 68(1):19-25. PubMed ID: 6166278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinetics of human interferon clearance in gibbons.
    Skreko F; Zajac I; Bahnsen HP; Haff RF; Cantell K
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):946-7. PubMed ID: 4692028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Distribution of human interferon in organs and tissues after its administration to man and animals].
    Maiakova SA; Berulava II; Gavrilova IE; Kuznetsov VP
    Vopr Virusol; 1980; (5):594-6. PubMed ID: 6159738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating human interferon after intramuscular injection into animals and man.
    Cantell K; Pyhälä L; Strander H
    J Gen Virol; 1974 Dec; 25(3):453-5. PubMed ID: 4443796
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.
    Merigan TC; Sikora K; Breeden JH; Levy R; Rosenberg SA
    N Engl J Med; 1978 Dec; 299(26):1449-53. PubMed ID: 362211
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating interferon in man after administration of exogenous human leukocyte interferon.
    Emödi G; Just M; Hernandez R; Hirt HR
    J Natl Cancer Inst; 1975 May; 54(5):1045-9. PubMed ID: 1127735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of human leukocyte interferon.
    Cantell K; Pyhälä L
    J Infect Dis; 1976 Jun; 133 Suppl():A6-12. PubMed ID: 932506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I pharmacotoxicology study of human fibroblast interferon in human cancers.
    McPherson TA; Tan YH
    J Natl Cancer Inst; 1980 Jul; 65(1):75-9. PubMed ID: 6156261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experiences with human fibroblast interferon (author's transl)].
    Furue H; Komita T; Kobayashi H; Hakozaki M; Kondo S; Tajima S
    Nihon Gan Chiryo Gakkai Shi; 1981 Apr; 16(2):220-8. PubMed ID: 6168714
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits.
    Vilcek J; Sulea IT; Zerebeckyj IL; Yip YK
    J Clin Microbiol; 1980 Jan; 11(1):102-5. PubMed ID: 7354125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunofluorescence method of study of biosynthesis of human interferon].
    Petukhova MB; Blinova EN; Karmysheva VIa; Ershov FI
    Vopr Virusol; 1978; (4):450-2. PubMed ID: 373250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two antigenically distinct species of human interferon.
    Havell EA; Berman B; Ogburn CA; Berg K; Paucker K; Vilcek J
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2185-7. PubMed ID: 49055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim report on studies on "toxic" effects of human leucocyte-derived interferon-alpha (HuIFN-alpha).
    Scott GM; Wallace J; Tyrrell DA; Cantell K; Secher DS; Stewart WE
    J Interferon Res; 1982; 2(1):127-30. PubMed ID: 6180101
    [No Abstract]   [Full Text] [Related]  

  • 18. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.
    Billiau A; De Somers P; Edy VG; De Clercq E; Heremans H
    Antimicrob Agents Chemother; 1979 Jul; 16(1):56-63. PubMed ID: 475375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of human fibroblast interferon in chronic hepatitis-B infection.
    Desmyter J; De Groote J; Desmet VJ; Billiau A; Ray MB; Bradburne AF; Edy VG; De Somer P
    Lancet; 1976 Sep; 2(7987):645-7. PubMed ID: 60513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon status and the activity of dsRNA-dependent enzymes in volunteers and influenza patients receiving human recombinant alpha 2-interferon (reaferon)].
    Lavrukhina LA; Sokolova TM; Suetina IA; Kniazeva LD; Mironova LL
    Vopr Virusol; 1988; 33(5):580-5. PubMed ID: 2464241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.